News

With more than 1.5 million people now using weight-loss drugs in the UK, the number-crunchers say that actuarial calculations ...
The DWTS alum shared a post on Instagram, in which she addressed speculation about her appearance, including rumors that ...
The morbidly obese members of the so-called National Association to Advance Fat Acceptance (NAAFA) have predictably come out ...
It’s no secret that obesity is becoming an epidemic in the United  States. It’s estimated that by 2030, 50 percent of ...
Doctors and many patients say GLP-1 drugs can help solve the growing problem of obesity. But some bristle at the thought that ...
As the cost of Mounjaro jabs is set to increase by as much as 170 per cent, Jade Kay, who has already spent £2.4k on the drug ...
Two new studies that have been published recently show that people who have been taking weight loss drugs may have ...
Studies have linked GLP-1 medications to various eye conditions, some of which may lead to vision loss. Despite these ...
An Iowa pharmacy that has been sued by business partners for millions of dollars is now being sanctioned by the state for distributing counterfeit Ozempic.
Oral semaglutide, known as the oral version of Ozempic, is revolutionising chronic disease management beyond just blood sugar control. This GLP-1 receptor agonist offers significant benefits including ...
Trump’s push for price cuts and tariffs weighs on ‘obesity franchises’, which have missed out on equity market’s rise ...
Uncover the truth about GLP-1 weight loss drugs like Ozempic and Mounjaro. Learn how they work, who benefits most, potential risks, and why experts say they can be game-changing tools for fighting ...